Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Oral Ifetroban in Subjects With Duchenne Muscular DystrophyNCT03340675Cumberland PharmaceuticalsPhase 2Completed2024-03-06Actual
Phase 2 Dose-finding IMU-838 for Ulcerative ColitisNCT03341962Immunic AGPhase 2Terminated2022-11-16Actual
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)NCT03363841SCYXPhase 3Completed2023-04-14Actual
Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's LymphomaNCT03364231TGTXPhase 2Completed2022-02-15Actual
Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative ColitisNCT03368118ABVXPhase 2Completed2022-07-12Actual
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type InsomniaNCT03373201Vanda PharmaceuticalsPhase 3Completed2018-03-05Actual
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaNCT03377179RedHill Biopharma LimitedPhase 2Completed2022-06-21Actual
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)NCT03377491NVCRPhase 3Completed2024-10-16Actual
CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRSNCT03401190CALCPhase 2Completed2019-02-14Actual
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseNCT03404115ALDXPhase 2Completed2018-07-11Actual
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate CancerNCT03414034Cardiff OncologyPhase 2Completed2023-10-16Actual
Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) InfectionNCT03421743SVRAPhase 2Completed2019-10-15Actual
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 PolymorphismsNCT03427060AKARI TherapeuticsPhase 2Completed2018-11-15Actual
A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisNCT03427125ArdelyxPhase 3Completed2019-11-15Actual
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive KeratoconusNCT03442751Glaukos CorporationPhase 3Completed2019-11-01Actual
Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery PatientsNCT03459287Cerus CorporationPhase 3Completed2023-12-04Actual
Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic AsthmaNCT03469934ANABPhase 2Completed2018-10-30Actual
A Long Term Safety Study of BCX7353 in Hereditary AngioedemaNCT03472040BioCryst PharmaceuticalsPhase 2, Phase 3Completed2022-04-27Actual
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisNCT03482752SVRAPhase 3Terminated2021-01-14Actual
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the KneeNCT03485157MDXGPhase 2Completed2022-04-19Actual
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial CancerNCT03485729Jazz PharmaceuticalsPhase 2Terminated2023-01-19Actual
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAENCT03485911BioCryst PharmaceuticalsPhase 3Completed2019-04-10Actual
Cantharidin and Occlusion in Verruca EpitheliumNCT03487549VRCAPhase 2Completed2019-05-16Actual
Open Label Extension Study of AMX0035 in Patients With ALSNCT03488524AMLXPhase 2Completed2021-03-01Actual
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)NCT03493685TVTXPhase 3Completed2023-03-20Actual
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisNCT03494504ALDXPhase 3Completed2018-11-05Actual
PRISM Study-Pruritus Relief Through Itch Scratch ModulationNCT03497975Trevi TherapeuticsPhase 2, Phase 3Completed2022-05-10Actual
VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2NCT03499795Inovio PharmaceuticalsPhase 2Completed2020-06-16Actual
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.NCT03507790Cognition TherapeuticsPhase 2Completed2024-05-29Actual
A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSDNCT03508700Tonix Pharmaceuticals, Inc.Phase 3Completed2019-09-30Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.